You are here: Industry Insights > US

News List

Insulin Price More Than Doubled in the United States drugs
January 24, 2019
Some Americans with type 1 diabetes have cut back on their insulin usage as the cost of the drug nearly doubled over a five-year period.....
Sandoz launches SYMJEPI in the US americanpharmaceuticalreview
January 21, 2019
Sandoz announced the US market introduction of SYMJEPI (epinephrine) 0.3 mg Injection for the emergency treatment of allergic reactions (Type 1), including anaphylaxis.....
US lawmakers to introduce new bills to slash prescription drug prices pharmaceutical-technology
January 15, 2019
US Senator Bernie Sanders and Representative Elijah Cummings have announced plans to introduce three new bills to reduce the price of prescription drugs in the country.
Celltrion/Teva’s Herceptin biosimilar approved in US pharmaphorum
December 18, 2018
The FDA has approved Celltrion and Teva’s biosimilar of Roche’s breast cancer drug Herceptin, the second potential competitor to the cancer blockbuster in the US.
Shire purchase backed by Takeda shareholders pharmatimes
December 07, 2018
Takeda announced in May this year a deal to buy the firm, after having its merger proposals previously turned down four times by Shire.
Sun Pharma's New Jersey manufacturing overhaul puts 96 jobs at risk pharmafile
November 28, 2018
Indian pharma firm Sun Pharma has announced it is to combine its New Jersey manufacturing operations in a bid to “improve cost efficiencies, it has emerged – a move which puts almost 100 jobs at risk.
Aurobindo Pharma to launch oncology, respiratory products in US by 2021 expressbpd
November 19, 2018
For the long term, from 2022 onwards, Aurobind Pharma plans “launch of inhalers, transdermals, biosimilars, and branded (both Rx and OTC) products in advanced markets,” the presentation said.
Aurobindo Pharma to launch oncology, respiratory products in US by 2021 expressbpd
November 19, 2018
For the long term, from 2022 onwards, Aurobind Pharma plans “launch of inhalers, transdermals, biosimilars, and branded (both Rx and OTC) products in advanced markets,” the presentation said.
United Therapeutics buys Arena's hypertension drug ralinepag in deal worth $1.2 billion pharmafile
November 19, 2018
US pharma firm United Therapeutics has agreed to by Arena Pharmaceuticals experimental pulmonary arterial hypertension (PAH) drug ralinepag in a deal worth up to more than $1.2 billion.
Grunenthal establishes commercial footprint in the US biospectrumasia
November 19, 2018
Averitas Pharma will be commercialising the pain patch Qutenza (8% capsaicin) for Grunenthal in the US.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 19 20 Next page